Literature DB >> 22381396

New perspectives on the dynamic behaviour of oral lichen planus.

Virginia García-García1, Antonio Bascones Martínez, Carla P Martinelli-Kläy, Emilio Alvarez Fernández, Tommaso Lombardi, Roger Küffer.   

Abstract

Lichen planus, a chronic inflammatory disease that affects the skin and mucous membranes, is one of the most frequent dermatological disorders of the oral cavity. The prevalence of oral lichen planus ranges from 0.2% to 4%. The triggering factors remain unknown. Oral lichen planus can be considered to be a chronic disease of long duration with a dynamic evolution and frequent changes in clinical appearance. Three successive active stages can be distinguished, without sharp limits between them: an initial stage; a protracted intermediate stage with alternate periods of variable activity and quiescence, which carries a progressively increasing risk of malignant transformation; and a late stage that often ends in a clinically little-known, inactive cicatricial post-lichen stage, which does not respond to steroid treatment but retains the same risk.

Entities:  

Mesh:

Year:  2012        PMID: 22381396     DOI: 10.1684/ejd.2011.1612

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  3 in total

1.  [Squamous cell carcinoma developing in oral lichen planus].

Authors:  N Thiessen; M Alter; A Kapp; R Gutzmer
Journal:  Hautarzt       Date:  2013-11       Impact factor: 0.751

2.  Histopathological characterization of the oral lichenoid disease subtypes and the relation with the clinical data.

Authors:  J Alberdi-Navarro; X Marichalar-Mendia; M-J Lartitegui-Sebastián; M-L Gainza-Cirauqui; M-A Echebarria-Goikouria; J-M Aguirre-Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

3.  Increased salivary aldehyde dehydrogenase 1 in non-reticular oral lichen planus.

Authors:  Arash Mansourian; Najmeh Shanbehzadeh; Seyed Javad Kia; Mahdieh-Sadat Moosavi
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.